abstract |
The present invention provides a therapeutic agent for endometriosis or adenomyosis.n n n The present invention specifically specifies that IL-33 is an exacerbating factor for endometriosis or adenomyosis, and finds that an IL-33 antagonist that can inhibit the action of IL-33 in endometriosis or uterine gland It is useful for the treatment, prevention, or alleviation of myopathy. |